Hepatocellular carcinoma in the thalassaemia syndromes
- PMID: 14675416
- DOI: 10.1046/j.1365-2141.2003.04732.x
Hepatocellular carcinoma in the thalassaemia syndromes
Abstract
Hepatocellular carcinoma (HCC) frequently complicates hepatic cirrhosis secondary to viral infection or iron overload. Therefore, patients affected by thalassaemia syndromes have a theoretically high risk of developing the tumour. We collected data on patients attending Italian centres for the treatment of thalassaemia. Twenty-two cases of HCC were identified; 15 were male. At diagnosis, the mean age was 45 +/- 11 years and the mean serum ferritin was 1764 +/- 1448 microg/l. Eighty-six percent had been infected by hepatitis C virus. Nineteen of 22 cases were diagnosed after 1993, suggesting that this problem is becoming more frequent with the aging population of thalassaemia patients.
Similar articles
-
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.Br J Haematol. 2014 Oct;167(1):121-6. doi: 10.1111/bjh.13009. Epub 2014 Jul 3. Br J Haematol. 2014. PMID: 24992281
-
Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience.Br J Haematol. 2010 Jul;150(2):245-7. doi: 10.1111/j.1365-2141.2010.08180.x. Epub 2010 Apr 28. Br J Haematol. 2010. PMID: 20433678 No abstract available.
-
Hepatocellular Carcinoma in a β-Thalassemia Intermedia Patient: Yet Another Case in the Expanding Epidemic.Hemoglobin. 2018 Jan;42(1):58-60. doi: 10.1080/03630269.2018.1434197. Epub 2018 Mar 1. Hemoglobin. 2018. PMID: 29493312
-
Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis.Ann Hepatol. 2013 Jan-Feb;12(1):142-6. Ann Hepatol. 2013. PMID: 23293206 Review.
-
Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review.Cancer. 2017 Mar 1;123(5):751-758. doi: 10.1002/cncr.30462. Epub 2016 Dec 1. Cancer. 2017. PMID: 27911488 Review.
Cited by
-
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021.Cancer. 2023 Jan 1;129(1):107-117. doi: 10.1002/cncr.34509. Epub 2022 Nov 2. Cancer. 2023. PMID: 36321594 Free PMC article.
-
Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies.Int J Mol Sci. 2023 Aug 10;24(16):12654. doi: 10.3390/ijms241612654. Int J Mol Sci. 2023. PMID: 37628834 Free PMC article. Review.
-
Treating thalassemia major-related iron overload: the role of deferiprone.J Blood Med. 2012;3:119-29. doi: 10.2147/JBM.S27400. Epub 2012 Oct 19. J Blood Med. 2012. PMID: 23112580 Free PMC article.
-
Measurement of liver fat fraction and iron with MRI and MR spectroscopy techniques.Diagn Interv Radiol. 2014 Jan-Feb;20(1):17-26. doi: 10.5152/dir.2013.13124. Diagn Interv Radiol. 2014. PMID: 24047718 Free PMC article. Review.
-
A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience.Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020006. doi: 10.4084/MJHID.2020.006. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 31934316 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical